Gabelli & Co Investment Advisers’s Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 JWSM.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding JWSM.WS
RCM
DC
EAM
SBLIC
CCM
AS
ACA
LIM
Gabelli & Co Investment Advisers's JWSM.WS Position: Q4 2024 in Review
Gabelli & Co Investment Advisers sold out of Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (JWSM.WS) in Q4 2024, closing a stake of 12,567 shares — an estimated $290 sold.
Gabelli & Co Investment Advisers first reported a position in JWSM.WS in Q2 2021 and held it in 14 quarters. The position peaked at $16K in Q2 2021. 9 funds tracked by Wall St. Rank hold JWSM.WS as of Q4 2024.
- Gabelli & Co Investment Advisers reported no remaining Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q4 2024 after selling out during the quarter.
- Gabelli & Co Investment Advisers sold 12,567 Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q4 2024, an estimated $290.
- Gabelli & Co Investment Advisers first reported a position in Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q2 2021 and held it in 14 quarters.
- Gabelli & Co Investment Advisers's Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $16K in Q2 2021.
- 9 funds tracked by Wall St. Rank held Jaws Mustang Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q4 2024.
Based on Gabelli & Co Investment Advisers's 13F filing for Q4 2024, filed 13 Feb 2025.